Media coverage about CRH Medical (CVE:CRM) has been trending positive this week, according to InfoTrie. InfoTrie identifies negative and positive press coverage by analyzing more than 6,000 blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CRH Medical earned a news sentiment score of 2.17 on their scale. InfoTrie also gave news stories about the company an news buzz score of 0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company’s share price in the next several days.
CRH Medical has a fifty-two week low of C$83.00 and a fifty-two week high of C$128.87.
In other CRH Medical news, Senior Officer Richard Bear sold 12,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 19th. The stock was sold at an average price of C$4.88, for a total value of C$58,608.00. Following the sale, the insider now owns 353,000 shares of the company’s stock, valued at approximately C$1,724,052. Also, Director Ian A. Webb sold 6,300 shares of the firm’s stock in a transaction that occurred on Monday, December 23rd. The shares were sold at an average price of C$4.66, for a total value of C$29,358.00. Following the completion of the sale, the director now directly owns 147,200 shares in the company, valued at approximately C$685,952.
CRH Medical Company Profile
CRH Medical Corporation (CRH) specializes in the distribution of medical products directly to physicians, particularly those in the gastroenterologist community. The Company’s lead product, the CRH O’Regan System, is a single use, disposable, hemorrhoid treatment that is used in treating hemorrhoid grades I-IV.
Featured Story: 52-Week High/Low Prices For Stock Selection
Receive News & Ratings for CRH Medical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CRH Medical and related companies with MarketBeat.com’s FREE daily email newsletter.